Special Issue
Topic: Biomarker Discovery and Precision Medicine
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 30 Jun 2019
Guest Editor(s)
Special Issue Introduction
With advances of genomics, transcriptomics, proteomics and metabolomics, blooming data have been available for exploring molecular alternations in cancers. Many of these molecular alternations have been investigated as biomarkers for cancer diagnosis, prognosis and precision therapies. Indeed, the success of most targeted anticancer therapies, such as inhibitors for EGFR, ALK, BRAF, and PARP as cancer therapies relies on biomarker-directed precision therapy. This Special Issue contains several articles in the areas of discovery of biomarkers, precision medicine and immune oncology. It is now clear that cancers with the same origins, clinical stages, and histopathologic diagnoses can be highly heterogeneous in responses to targeted therapeutic agents and immune checkpoint therapies. Various clinical trials have been shown that only a subgroup of patients benefit from pathway-targeted therapy and immune checkpoint therapies. The inability to identify patients likely to respond to a treatment is one of the major challenges in the early stages of clinical trials of anticancer agents and in clinical practice with some approved anticancer agents. Thus, identification of biomarkers capable of predicting treatment responses is crucial for targeted therapies and immunotherapies of cancers. The articles in this Special Issues discuss and/or report recent advances in discoveries of biomarkers, precision medicine and immune oncology, including strategies, experimental approaches, technologies, and clinical validations and applications. I hope this issue will provide our readers with helpful information about recent advances and achievements in this evolving field.
Keywords
Target therapies, pathway targeted therapies, small molecular inhibitors, biomarkers, gene mutations, epigenetics, molecular signatures, clinical trials, metastasis, cancer stem cells, combinational therapy, precision therapies
Submission Deadline
30 Jun 2019
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt
Submission Deadline: 30 Jun 2019
Contacts: Alice Qian, Assistant Editor, editor002@jcmtjournal.com
Published Articles
Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”
Open Access Editorial 6 Jan 2020
Views: Downloads:
The immunological regulation of cancer cachexia and its therapeutic implications
Open Access Review 29 Sep 2019
Views: Downloads:
Membrane lipid binding molecules for the isolation of bona fide extracellular vesicle types and associated biomarkers in liquid biopsy
Open Access Review 2 Sep 2019
Views: Downloads:
Monoclonal antibodies to the exon 18 encoded moiety of NCAM
Open Access Original Article 19 Jul 2019
Views: Downloads:
Sensitive and specific detection of circulating tumor cells promotes precision medicine for cancer
Open Access Review 20 Apr 2019
Views: Downloads:
Peripheral biomarkers for pediatric brain tumors: current advancements and future challenges
Open Access Review 18 Apr 2019
Views: Downloads:
Window of opportunity trials in head and neck cancer
Open Access Review 17 Mar 2019
Views: Downloads:
A pilot study for distinguishing basal cell carcinoma from normal human skin tissues using visible resonance Raman spectroscopy
Open Access Original Article 22 Jan 2019
Views: Downloads:
Mass spectrometry-based metabolomic profiling of prostate cancer - a pilot study
Open Access Original Article 7 Jan 2019
Views: Downloads:
Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study)
Open Access Original Article 27 Dec 2018
Views: Downloads: